Overview TG Therapeutics’ Phase 2 study in generalized myasthenia gravis put the logic of several studies inside one protocol: multiple treatment pathways, blinded and..
Overview TG Therapeutics’ Phase 2 study in generalized myasthenia gravis put the logic of several studies inside one protocol: multiple treatment pathways, blinded and..
Overview Personalized medicine trials don’t fit the standard RTSM software model. When every patient receives a custom-manufactured therapy, the supply..
Overview A clinical-stage genetic medicines company is pioneering precision delivery technologies for mRNA and gene correction therapeutics. They are developing..
Overview A clinical-stage oncology biotech was running a live Phase I study using manual enrollment and drug supply workflows, with..
Overview A clinical-stage oncology biotech running early Phase I studies needed an RTSM software that could keep pace with a..